FOOD AND DRUG ADMINISTRATION (FDA) Center for Drug Evaluation and Research (CDER) Peripheral and Central Nervous System Drugs Advisory Committee (PCNS) Meeting Sheraton Silver Spring Hotel, Cypress Ballroom 8777 Georgia

First Page		Document Content
Research Clinical research Pharmaceutical industry Food and Drug Administration Cyclopropanes Tasimelteon Non-24-hour sleep-wake disorder New Drug Application Pharmaceutical sciences Health Pharmacology		FOOD AND DRUG ADMINISTRATION (FDA) Center for Drug Evaluation and Research (CDER) Peripheral and Central Nervous System Drugs Advisory Committee (PCNS) Meeting Sheraton Silver Spring Hotel, Cypress Ballroom 8777 Georgia Add to Reading List Source URL: www.fda.gov Download Document from Source Website File Size: 24,78 KB Share Document on Facebook

	Communication pubs.acs.org/JACS Highly Diastereo- and Enantioselective Synthesis of TriﬂuoromethylSubstituted Cyclopropanes via Myoglobin-Catalyzed Transfer of Triﬂuoromethylcarbene Antonio Tinoco, Viktoria Steck, Vi DocID: 1uSIY - View Document
	New Drugs Approved in FY 2015 Review Category Approval Date No. DocID: 1r3Vv - View Document
	Microsoft Word - GILEAD BRIEFING DocID: 1r2Vm - View Document
	Treatment of Chronic Hepatitis C - January 2016 Update (The changes compared to the November 2015 Update are highlighted in yellow) Swiss Association for the Study of the Liver and Swiss Society for Infectious Diseases DocID: 1qOAQ - View Document
	Personalized Medicine Using genetic information to Help Fight Disease Personalized medicine is changing the way patients with Hepatitis C are treated…and cured.1 What is Personalized Medicine? DocID: 1qCC6 - View Document